Equillium, Inc. Quarterly Operating Income (Loss) in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Equillium, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2017 to Q3 2024.
  • Equillium, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$679K, a 81.3% increase year-over-year.
  • Equillium, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.77M, a 27% increase year-over-year.
  • Equillium, Inc. annual Operating Income (Loss) for 2023 was -$14.5M, a 76.6% increase from 2022.
  • Equillium, Inc. annual Operating Income (Loss) for 2022 was -$62.1M, a 64.3% decline from 2021.
  • Equillium, Inc. annual Operating Income (Loss) for 2021 was -$37.8M, a 27.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$6.77M -$679K +$2.94M +81.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$9.71M -$100K +$3.49M +97.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$13.2M -$2.79M +$1.32M +32.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$14.5M -$3.2M -$5.24M -257% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$9.28M -$3.62M +$9.61M +72.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$18.9M -$3.59M +$9.96M +73.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$28.9M -$4.11M +$33.2M +89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$62.1M $2.04M +$12.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$74.5M -$13.2M -$3.38M -34.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$71.1M -$13.6M -$4.71M -53.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$66.4M -$37.3M -$28.6M -329% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$37.8M -$10.4M -$1.42M -15.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$36.4M -$9.86M -$3.35M -51.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$33M -$8.84M -$2.23M -33.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$30.8M -$8.7M -$1.24M -16.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$29.5M -$8.97M -$1.35M -17.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$28.2M -$6.52M -$192K -3.04% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$28M -$6.61M -$171K -2.66% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$27.8M -$7.45M -$1.1M -17.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$26.7M -$7.62M -$3.39M -80.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$23.3M -$6.32M -$4.1M -184% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$19.2M -$6.44M -$5.31M -472% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$13.9M -$6.35M -$5.31M -512% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$8.62M -$4.23M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$2.23M -$2.14M -2559% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.13M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$1.04M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 -$83.7K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.